Claims Payer Observability Checklist

What it is

- This guideline is the checklist layer for payer and enrollment observability in claims-based RWE. It keeps the checklist out of concept files and gives analysts a concrete gate before they build exposure, outcome, cost, adherence, or covariate variables from claims. The central question is not "is the patient insured?" but "is the needed data channel observable for this patient-month, plan, benefit, and vendor extract?" Medicare Parts A, B, C, and D, LIS, dual eligibility, entitlement reason, subscriber/member identifiers, ERISA funding status, and benefit carve-outs all change what the dataset can see.

When to use

- Use it before claims-based cohort construction, especially when the study depends on complete medical claims, Part D or PBM fills, specialty pharmacy, behavioral health, site-of-care costs, cost sharing, socioeconomic proxies, or family/subscriber relationships. It applies to Medicare FFS, Medicare Advantage encounter data, Medicaid-linked Medicare, and commercial claims from carriers, third-party administrators, employers, PBMs, and multi-source aggregators. Use it again when defining analytic censoring rules, because a move into Medicare Advantage, a pharmacy carve-out, or missing PBM feed can create unobservable person-time that looks like no use or no event.

What it requires / checklist domains

- Build a month-level eligibility and benefit panel before interpreting claims. Confirm which channel is required for each endpoint or exposure: Part A/B FFS medical events, Part D retail fills, Part B administered drugs, commercial medical, commercial pharmacy, specialty pharmacy, behavioral health, lab, or dental/vision ancillary feeds. Separate member/person identifiers from subscriber/family identifiers. Identify plan funding and administration where possible, including self-insured ERISA plans and third-party administrators. For Medicare, explicitly carry A/B/C/D, LIS, dual eligibility, and reason for entitlement; Medicare has Parts A-D, and "Part E" should be treated as an informal/local term requiring clarification, not as an official benefit.

When NOT to use - limitations and common misapplications

- Do not use this checklist as a substitute for outcome validation or confounding control; it only verifies observability. Do not infer no medication use from absence of pharmacy claims when the pharmacy benefit is carved out. Do not infer no hospitalization from absent FFS claims during Medicare Advantage months unless MA encounter data are proven complete for the question. Do not de-duplicate people on subscriber ID alone, because a subscriber can cover multiple members. Do not treat LIS, dual status, or entitlement reason as static if month-level fields are available. Missing payer data are often a structural data limitation, not a patient behavior.

How it maps to this catalog

- This guideline cross-references `medicare-entitlement-lis-dual-eligibility-rwe` for Medicare parts, LIS, dual, and entitlement fields; `subscriber-id-member-id-claims-rwe` for identifier grain; `erisa-self-insured-health-plans-rwe` for commercial plan funding; `benefit-carve-outs-medical-pharmacy-rwe` for missing benefit channels; `claims-analysis` for source mechanics; and `continuous-enrollment-observable-time-rwe` for the observable-time denominator. Use FDA's EHR/claims data guidance for the broader data reliability/relevance frame; use this checklist for the payer-channel appendix.